NCT00497562View on ClinicalTrials.gov

Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2004

Study Completion Date

November 30, 2005

Conditions
FibromyalgiaGrowth Hormone Deficiency
Interventions
DRUG

sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group)

DRUG

amitriptyline, fluoxetine and tramadol alone (control group)

Trial Locations (1)

08022

Endocrinology Department CM Teknon, Barcelona

All Listed Sponsors
lead

Centro Medico Teknon

OTHER

NCT00497562 - Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters) | Biotech Hunter | Biotech Hunter